Conformal Barrier and Hidden Local Symmetry Constraints: Walking Technirhos in LHC Diboson Channels

We expand the previous analyses of the conformal barrier on the walking technirho for the 2 TeV diboson excesses reported by the ATLAS collaboration, with a special emphasis on the hidden local symmetry (HLS) constraints. We first show that the Standard Model (SM) Higgs Lagrangian is equivalent to the scale-invariant nonlinear chiral Lagrangian, which is further gauge equivalent to the scale-invariant HLS model, with the scale symmetry realized nonlinearly via SM Higgs as a (pseudo-) dilaton. The scale symmetry forbids the new vector boson decay to the 125 GeV Higgs plus W/Z boson, in sharp contrast to the conventional "equivalence theorem" which is invalidated by the conformality. The HLS forbids mixing between the iso-triplet technirho's, rho_{Pi} and rho_{P}, of the one-family walking technicolor (with four doublets N_D=N_F/2=4), which, without the HLS, would be generated when switching on the standard model gauging. We also present updated analyses of the walking technrho's for the diboson excesses by fully incorporating the constraints from the conformal barrier and the HLS as well as possible higher order effects: still characteristic of the one-family walking technirho is its smallness of the decay width, roughly of order Gamma/M_rho ~ [3/N_C x 1/N_D] x [Gamma/M_rho]_{QCD} ~ 70 GeV/2TeV (N_D= N_C=4), in perfect agreement with the expected diboson resonance with Gamma<100 GeV. The model is so sharply distinguishable from other massive spin 1 models without the conformality and HLS that it is clearly testable at the LHC Run II. If the 2 TeV boson decay to WH/ZH is not observed in the ongoing Run II, then the conformality is operative on the 125 GeV Higgs, strongly suggesting that the 2 TeV excess events are responsible for the walking technirhos and the 125 GeV Higgs is the technidilaton.Comment: latex, 12 eps figures, 36 pages; minor corrections made in theory part, version published in NP

2 TeV Walking Technirho at LHC?

The ATLAS collaboration has recently reported an excess of about 2.5 $\sigma$ global significance at around 2 TeV in the diboson channel with the boson-tagged fat dijets, which may imply a new resonance beyond the standard model. We provide a possible explanation of the excess as the isospin-triplet technivector mesons (technirhos, denoted as $\rho_\Pi^{\pm,3}$) of the walking technicolor in the case of the one-family model as a benchmark. As the effective theory for the walking technicolor at the scales relevant to the LHC experiment, we take a scale-invariant version of the hidden local symmetry model so constructed as to accommodate technipions, technivector mesons, and the technidilaton in such a way that the model respects spontaneously broken chiral and scale symmetries of the underlying walking technicolor. In particular, the technidilaton, a (pseudo) Nambu-Goldstone boson of the (approximate) scale symmetry predicted in the walking technicolor, has been shown to be successfully identified with the 125 GeV Higgs. Currently available LHC limits on those technihadrons are used to fix the couplings of technivector mesons to the standard-model fermions and weak gauge bosons. We find that the technirho's are mainly produced through the Drell-Yan process and predominantly decay to the dibosons, which accounts for the currently reported excess at around 2 TeV. The consistency with the electroweak precision test and other possible discovery channels of the 2 TeV technirhos are also addressed.Comment: 8 pages, 4 eps figures, latex; version to appear in PL

Serotonin- and Somatostatin-Positive Goblet Cell Carcinoid of the Duodenum

In the duodenum, mixed exocrine-endocrine tumors exhibiting both neuroendocrine and glandular differentiations [cf. appendiceal goblet cell carcinoids (GCCs)] are rare. We present a Japanese case with a duodenal GCC that was found during pathologic examination of a gastrectomy specimen removed for gastric mucosal cancer. The tumor was widely distributed within both the first portion of the duodenum and the gastric antrum, although mucosal involvement was observed only in the duodenum. The tumor cells formed solid nests, trabeculae, or tubules, and some displayed a goblet cell appearance. They were immunoreactive against antibodies for both serotonin and somatostatin, and showed an argentaffin reaction (similar to a “midgut” enterochromaffin cell carcinoid). Ultra-structurally, the tumor cells had an amphicrine nature. Physicians encounter GCC in the duodenum only rarely, and its discovery may be incidental. Its diagnosis will be challenging and will require careful clinical and pathologic examinations

Human intestinal spirochetosis accompanied by human immunodeficiency virus infection:a case report

We present a middle-aged, heterosexual Japanese man with mixed infections including human intestinal spirochetosis, which led us to the detection of human immunodeficiency virus (HIV) infection. The patient had syphilis without related physical or neurological findings. An examination for the serum antibody for HIV performed 9 years previously was negative. In a complete medical checkup at the present time, human intestinal spirochetosis and unspecified entamebic cysts were suggested by histological examination of colonic biopsy material and parasitic examination of the intestinal fluid, respectively. Moreover, a serological test for the antibody for HIV was positive. In specimens obtained by colonoscopy, Brachyspira aalborgi was diagnosed by ultrastructural study and the polymerase chain reaction method for bacterial 16S ribosomal deoxyribonucleic acid. Although HIV infection remains at low prevalence in Japan, we recommend examination for HIV infection in patients with human intestinal spirochetosis, especially when other co-infections are apparent.</p

Transarterial embolization for convexity dural arteriovenous fistula

Background: Convexity dural arteriovenous fistulae (dAVF) usually reflux into cortical veins without involving the venous sinuses. Although direct drainage ligation is curative, transarterial embolization (TAE) may be an alternative treatment. Case Description: Between September 2018 and January 2021, we encountered four patients with convexity dAVFs. They were three males and one female; their age ranged from 36 to 73 years. The initial symptom was headache (n = 1) or seizure (n = 2); one patient was asymptomatic. In all patients, the feeders were external carotid arteries with drainage into the cortical veins; in two patients, there was pial arterial supply from the middle cerebral artery. All patients were successfully treated by TAE alone using either Onyx or N-butyl cyanoacrylate embolization. Two patients required two sessions. All dAVFs were completely occluded and follow-up MRI or angiograms confirmed no recurrence. Conclusion: Our small series suggests that TAE with a liquid embolic material is an appropriate first-line treatment in patients with convexity dAVFs with or without pial arterial supply

Alteration of Plasma Glutamate and Glutamine Levels in Children with High-Functioning Autism

浜松医科大学学位論文　医博第624号（平成24年3月19日

Essential anatomy for lateral lymph node dissection

In Western countries, the gold-standard therapeutic strategy for rectal cancer is preoperative chemoradiotherapy (CRT) following total mesorectal excision (TME), without lateral lymph node dissection (LLND). However, preoperative CRT has recently been reported to be insufficient to control lateral lymph node recurrence in cases of enlarged lateral lymph nodes before CRT, and LLND is considered necessary in such cases. We performed a literature review on aspects of pelvic anatomy associated with rectal surgery and LLND, and then combined this information with our experience and knowledge of pelvic anatomy. In this review, drawing upon research using a 3-dimensional anatomical model and actual operative views, we aimed to clarify the essential anatomy for LLND. The LLND procedure was developed in Asian countries and can now be safely performed in terms of functional preservation. Nonetheless, the longer operative time, hemorrhage, and higher complication rates with TME accompanied by LLND than with TME alone indicate that LLND is still a challenging procedure. Laparoscopic or robotic LLND has been shown to be useful and is widely performed; however, without a sufficient understanding of anatomical landmarks, misrecognition of vessels and nerves often occurs. To perform safe and accurate LLND, understanding the landmarks of LLND is essential

Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan

The version of record of this article, first published in International Journal of Clinical Oncology, is available online at Publisher’s website: https://doi.org/10.1007/s10147-024-02612-1.Background: In metastatic clear cell renal cell carcinoma (ccRCC), recent studies have shown promising efficacy of immune checkpoint inhibitor (ICI) combination therapy. However, there are insufficient evidences about clinical efficacy and safety of ICI combination therapy in metastatic non-ccRCC (nccRCC). Methods: We retrospectively investigated 44 patients treated with nivolumab plus ipilimumab (ICI + ICI group) or anti-PD-1/PD-L1 inhibitor plus tyrosine kinase inhibitors (TKI) (ICI + TKI group), and assessed clinical efficacy in both groups. Results: Of all patients, overall response rate and disease control rate for ICI combination treatments were 36.3% and 75%, respectively. The median progression-free survival (PFS) and overall survival (OS) was 8.8 and 23.9 months, respectively. Multivariate analysis revealed that the presence of liver metastasis significantly affected worse PFS and OS (p = 0.035 and p = 0.049). Importantly, PFS and OS seemed similar in ICI + ICI group and ICI + TKI group (p = 0.778 and p = 0.559). Although the discontinuation rate of the combination therapy due to adverse effects in patients aged ≥ 75 years was significantly higher compared to that in patients aged < 75 years (45% versus 12%, p = 0.017), there were no significant differences in PFS and OS between two groups (p = 0.290 and p = 0.257, respectively). Conclusion: This study confirms clinical benefit of ICI combination therapy for metastatic nccRCC patients in real-world settings. Furthermore, the effectiveness of combination therapy was comparable between patients aged < 75 and those ≥75 years with respect to clinical prognosis

Probiotic Bifidobacterium breve Induces IL-10-Producing Tr1 Cells in the Colon

Specific intestinal microbiota has been shown to induce Foxp3+ regulatory T cell development. However, it remains unclear how development of another regulatory T cell subset, Tr1 cells, is regulated in the intestine. Here, we analyzed the role of two probiotic strains of intestinal bacteria, Lactobacillus casei and Bifidobacterium breve in T cell development in the intestine. B. breve, but not L. casei, induced development of IL-10-producing Tr1 cells that express cMaf, IL-21, and Ahr in the large intestine. Intestinal CD103+ dendritic cells (DCs) mediated B. breve-induced development of IL-10-producing T cells. CD103+ DCs from Il10−/−, Tlr2−/−, and Myd88−/− mice showed defective B. breve-induced Tr1 cell development. B. breve-treated CD103+ DCs failed to induce IL-10 production from co-cultured Il27ra−/− T cells. B. breve treatment of Tlr2−/− mice did not increase IL-10-producing T cells in the colonic lamina propria. Thus, B. breve activates intestinal CD103+ DCs to produce IL-10 and IL-27 via the TLR2/MyD88 pathway thereby inducing IL-10-producing Tr1 cells in the large intestine. Oral B. breve administration ameliorated colitis in immunocompromised mice given naïve CD4+ T cells from wild-type mice, but not Il10−/− mice. These findings demonstrate that B. breve prevents intestinal inflammation through the induction of intestinal IL-10-producing Tr1 cells